Prediction and Validation of Metabolic Dysfunction-Associated Fatty Liver Disease Using Insulin Resistance-Related Indices in the Japanese Population
Metabolic Syndrome and Related Disorders · 2023
DOI: 10.1089/met.2023.0116 ↗Kurz gefasst
Fachartikel in der Zeitschrift Metabolic Syndrome and Related Disorders, 2023. Verfasst von Kengo Moriyama und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Health Science, Tokai University School of Medicine, Tokai University Hachioji Hospital, Tokyo, Japan. Hauptthemen laut MEDLINE: Insulin Resistance, Diabetes Mellitus, Type 2, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
Background
Recently, metabolic dysfunction-associated fatty liver disease (MAFLD), which is based on evidence of hepatic steatosis and any of the following three conditions: overweight/obesity, presence of type 2 diabetes mellitus, or evidence of metabolic dysregulation, has been proposed. It is uncertain how indices that predict insulin resistance (IR) are associated with MAFLD.
Methods
Among subjects who had undergone health examinations at our hospital, 1,257 (787 men and 474 women) who underwent fatty liver evaluation, were included in this cross-sectional study. The discriminatory ability of each index for MAFLD was tested using a receiver operating characteristic curve analysis. The associations between the homeostasis model assessment-IR (HOMA-IR), triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio, triglyceride-glucose (TyG) index, and MAFLD were investigated using multiple logistic regression analysis.
Results
The mean age and body mass index of MAFLD subjects were 58.1 years and 26.0 kg/m 2 in men and 63.0 years and 26.1 kg/m 2 in women, respectively. The cutoff values of HOMA-IR, TG/HDL-C ratio, and TyG index in men and women were 1.40 (area under the curve [AUC]: 0.81) and 1.90 (AUC: 0.88); 1.56 (AUC: 0.75) and 1.06 (AUC: 0.78); and 8.62 (AUC: 0.75) and 8.45 (AUC: 0.80), respectively. All indices were significantly higher in both men and women with MAFLD. In the multivariate models, the odds of MAFLD were higher among both men and women in the highest tertile than those in the lowest tertile. When subjects were divided by sex, presence of MAFLD, and alanine aminotransferase (ALT) values, all indices were significantly higher in both men and women with high ALT levels who were diagnosed with MAFLD.
Conclusion
IR strongly correlated with MAFLD, particularly in subjects with high ALT levels.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Health Science, Tokai University School of Medicine, Tokai University Hachioji Hospital, Tokyo, Japan.
- Department of Clinical Health Science, Tokai University School of Medicine, Tokai University Hospital, Kanagawa, Japan.
- Department of Clinical Health Science, Tokai University School of Medicine, Tokai University Tokyo Hospital, Tokyo, Japan.
ORCID-Profile: Kengo Moriyama, Yumi Masuda
Zitieren
APA
Moriyama, K., Inoue, N., Imai, J., Masuda, Y., Yamada, C., Kishimoto, N., Takashimizu, S., Kubo, A., & Nishizaki, Y. (2023). Prediction and Validation of Metabolic Dysfunction-Associated Fatty Liver Disease Using Insulin Resistance-Related Indices in the Japanese Population. Metabolic Syndrome and Related Disorders. https://doi.org/10.1089/met.2023.0116
Vancouver
Moriyama K, Inoue N, Imai J, Masuda Y, Yamada C, Kishimoto N, et al. Prediction and Validation of Metabolic Dysfunction-Associated Fatty Liver Disease Using Insulin Resistance-Related Indices in the Japanese Population. Metabolic Syndrome and Related Disorders. 2023. doi:10.1089/met.2023.0116
BibTeX
@article{Moriyama2023,
author = {Moriyama, Kengo and Inoue, Nagamu and Imai, Jin and Masuda, Yumi and Yamada, Chizumi and Kishimoto, Noriaki and Takashimizu, Shinji and Kubo, Akira and Nishizaki, Yasuhiro},
title = {Prediction and Validation of Metabolic Dysfunction-Associated Fatty Liver Disease Using Insulin Resistance-Related Indices in the Japanese Population},
journal = {Metabolic Syndrome and Related Disorders},
year = {2023},
doi = {10.1089/met.2023.0116}
}
EUVIMED